Triad Financial Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$749K Buy
4,810
+86
+2% +$14.2K 0.26% 40
2023
Q2
$782K Sell
4,724
-56
-1% -$9.04K 0.32% 36
2023
Q1
$741K Sell
4,780
-287
-6% -$46.3K 0.32% 38
2022
Q4
$895K Buy
5,067
+327
+7% +$56.5K 0.4% 33
2022
Q3
$774K Sell
4,740
-134
-3% -$22.7K 0.42% 33
2022
Q2
$865K Sell
4,874
-112
-2% -$20K 0.48% 28
2022
Q1
$884K Sell
4,986
-488
-9% -$83K 0.47% 29
2021
Q4
$937K Buy
+5,474
New +$896K 0.56% 29

Other funds holding JNJ

Triad Financial Advisors's JNJ Position: Q3 2023 in Review

Triad Financial Advisors increased its Johnson & Johnson (JNJ) stake by 1.8% in Q3 2023, buying an estimated $14.2K and bringing the position to 4,810 shares worth $749K. The position accounts for 0.26% of the portfolio, ranked #40.

Triad Financial Advisors first reported a position in JNJ in Q4 2021 and has held it in 8 quarters since. The position peaked at $937K in Q4 2021. 3,678 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

  • Triad Financial Advisors held 4,810 shares of Johnson & Johnson worth $749K as of Q3 2023.
  • Triad Financial Advisors bought 86 Johnson & Johnson shares in Q3 2023, an estimated $14.2K.
  • Johnson & Johnson made up 0.26% of Triad Financial Advisors's portfolio in Q3 2023, its #40 holding.
  • Triad Financial Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 8 quarters since.
  • Triad Financial Advisors's Johnson & Johnson position peaked at $937K in Q4 2021.
  • 3,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on Triad Financial Advisors's 13F filing for Q3 2023, filed 2 Nov 2023.